SOAR Program for Preventing Osteoarthritis After ACL Tear
(SOAR Trial)
Trial Summary
What is the purpose of this trial?
By 2040, 25% of Canadians will have osteoarthritis, a disabling joint condition. Most people think osteoarthritis only affects older adults, but 50% of the 700,000 Canadian youth who hurt their knee playing sports annually will develop osteoarthritis by 40 years of age. These young people with old knees face knee pain and disability for much of their adult lives, interfering with parenting, work, and recreation. Yet, most do not know about osteoarthritis or how to reduce their risk. In this clinical trial, people who have torn the Anterior Cruciate ligament in their knee and had reconstruction surgery 9-36 months previously will be randomized to receive either a 6-month virtual education and exercise therapy program called Stop OsteoARthritis (SOAR) or a minimal intervention control program. Researchers will test if those who received the SOAR program have larger gains in knee health, including pain, symptoms, function, and quality of life at 6, 12, and 24 months. Researchers will also use MRIs (baseline and 24 months) to assess how the SOAR program influences knee cartilage degeneration and its cost-effectiveness.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the SOAR treatment for preventing osteoarthritis after an ACL tear?
The SOAR treatment includes strategies like exercise, rehabilitation, and psychological skills training, which are recommended by experts to reduce the risk of osteoarthritis after an ACL injury. Additionally, early interventions and coordinated care models are suggested to help slow or prevent the progression of osteoarthritis.12345
How is the SOAR treatment different from other treatments for preventing osteoarthritis after an ACL tear?
The SOAR program is unique because it focuses on a comprehensive approach that includes patient education, exercise and rehabilitation, psychological skills training, and coordinated care models to prevent osteoarthritis after an ACL injury, rather than just addressing symptoms or using medication.15678
Research Team
Jackie L Whittaker, BScPT, PhD
Principal Investigator
University of British Columbia
Eligibility Criteria
This trial is for young adults aged 16-35 in British Columbia who had ACL reconstruction surgery 9-36 months ago. Participants should not be currently receiving other knee treatments, have limited knee function as measured by a KOOS4 score, and must have daily internet access to participate in virtual programs.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 6-month virtual education and exercise therapy program called Stop OsteoARthritis (SOAR) or a minimal intervention control program
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6, 12, and 24 months
MRI Assessment
MRI assessments to evaluate knee cartilage degeneration and other OA features
Treatment Details
Interventions
- Stop OsteoARthritis (SOAR) program
Stop OsteoARthritis (SOAR) program is already approved in Canada for the following indications:
- Prevention of osteoarthritis after ACL reconstruction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Arthritis Research Centre of Canada
Collaborator
The Arthritis Society, Canada
Collaborator